nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—ABCB1—kidney cancer	0.157	1	CbGaD
Mifepristone—CYP3A7—Temsirolimus—kidney cancer	0.0438	0.0693	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0438	0.0693	CbGbCtD
Mifepristone—ABCC1—Dactinomycin—kidney cancer	0.0425	0.0673	CbGbCtD
Mifepristone—CYP3A5—Temsirolimus—kidney cancer	0.0328	0.052	CbGbCtD
Mifepristone—ABCC1—Paclitaxel—kidney cancer	0.0304	0.0481	CbGbCtD
Mifepristone—ABCC1—Vinblastine—kidney cancer	0.0267	0.0422	CbGbCtD
Mifepristone—ABCC1—Vincristine—kidney cancer	0.0262	0.0415	CbGbCtD
Mifepristone—ABCB1—Temsirolimus—kidney cancer	0.0214	0.0338	CbGbCtD
Mifepristone—CYP2D6—Temsirolimus—kidney cancer	0.0201	0.0319	CbGbCtD
Mifepristone—CYP3A4—Everolimus—kidney cancer	0.019	0.03	CbGbCtD
Mifepristone—ABCC1—Doxorubicin—kidney cancer	0.0164	0.0259	CbGbCtD
Mifepristone—CYP3A7—Paclitaxel—kidney cancer	0.015	0.0238	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.015	0.0238	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0133	0.0211	CbGbCtD
Mifepristone—CYP3A7—Sorafenib—kidney cancer	0.0133	0.0211	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.013	0.0205	CbGbCtD
Mifepristone—CYP3A7—Vincristine—kidney cancer	0.013	0.0205	CbGbCtD
Mifepristone—CYP3A4—Temsirolimus—kidney cancer	0.0128	0.0203	CbGbCtD
Mifepristone—CYP3A5—Erlotinib—kidney cancer	0.0123	0.0195	CbGbCtD
Mifepristone—CYP3A5—Paclitaxel—kidney cancer	0.0113	0.0178	CbGbCtD
Mifepristone—ABCB1—Pazopanib—kidney cancer	0.0112	0.0178	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.0108	0.0171	CbGbCtD
Mifepristone—CYP3A7—Sunitinib—kidney cancer	0.0108	0.0171	CbGbCtD
Mifepristone—CYP2D6—Pazopanib—kidney cancer	0.0106	0.0167	CbGbCtD
Mifepristone—ABCB1—Dactinomycin—kidney cancer	0.0103	0.0162	CbGbCtD
Mifepristone—CYP3A5—Sorafenib—kidney cancer	0.01	0.0158	CbGbCtD
Mifepristone—CYP3A5—Vincristine—kidney cancer	0.00971	0.0154	CbGbCtD
Mifepristone—ABCB1—Gemcitabine—kidney cancer	0.00812	0.0128	CbGbCtD
Mifepristone—CYP3A5—Sunitinib—kidney cancer	0.00811	0.0128	CbGbCtD
Mifepristone—ABCB1—Erlotinib—kidney cancer	0.00801	0.0127	CbGbCtD
Mifepristone—CYP2D6—Erlotinib—kidney cancer	0.00755	0.0119	CbGbCtD
Mifepristone—ABCB1—Paclitaxel—kidney cancer	0.00733	0.0116	CbGbCtD
Mifepristone—CYP3A4—Pazopanib—kidney cancer	0.00673	0.0106	CbGbCtD
Mifepristone—ABCB1—Sorafenib—kidney cancer	0.00651	0.0103	CbGbCtD
Mifepristone—ABCB1—Vinblastine—kidney cancer	0.00643	0.0102	CbGbCtD
Mifepristone—ABCB1—Vincristine—kidney cancer	0.00632	0.01	CbGbCtD
Mifepristone—CYP2D6—Sorafenib—kidney cancer	0.00614	0.00971	CbGbCtD
Mifepristone—CYP2D6—Vinblastine—kidney cancer	0.00606	0.00959	CbGbCtD
Mifepristone—ABCB1—Sunitinib—kidney cancer	0.00528	0.00835	CbGbCtD
Mifepristone—CYP3A4—Erlotinib—kidney cancer	0.0048	0.00759	CbGbCtD
Mifepristone—CYP3A4—Paclitaxel—kidney cancer	0.00439	0.00695	CbGbCtD
Mifepristone—ABCB1—Doxorubicin—kidney cancer	0.00395	0.00625	CbGbCtD
Mifepristone—CYP3A4—Sorafenib—kidney cancer	0.0039	0.00618	CbGbCtD
Mifepristone—CYP3A4—Vinblastine—kidney cancer	0.00385	0.0061	CbGbCtD
Mifepristone—CYP3A4—Vincristine—kidney cancer	0.00379	0.006	CbGbCtD
Mifepristone—CYP2D6—Doxorubicin—kidney cancer	0.00372	0.00589	CbGbCtD
Mifepristone—CYP3A4—Sunitinib—kidney cancer	0.00316	0.005	CbGbCtD
Mifepristone—CYP3A4—Doxorubicin—kidney cancer	0.00237	0.00375	CbGbCtD
Mifepristone—NR3C1—urine—kidney cancer	0.00168	0.103	CbGeAlD
Mifepristone—CYP3A4—urine—kidney cancer	0.00127	0.0783	CbGeAlD
Mifepristone—CYP2D6—urine—kidney cancer	0.00125	0.077	CbGeAlD
Mifepristone—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.0011	0.0678	CbGeAlD
Mifepristone—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000942	0.058	CbGeAlD
Mifepristone—AR—renal system—kidney cancer	0.000567	0.035	CbGeAlD
Mifepristone—AR—kidney—kidney cancer	0.000548	0.0338	CbGeAlD
Mifepristone—AR—cortex of kidney—kidney cancer	0.000534	0.0329	CbGeAlD
Mifepristone—AR—gonad—kidney cancer	0.000509	0.0313	CbGeAlD
Mifepristone—AR—cardiac atrium—kidney cancer	0.000508	0.0313	CbGeAlD
Mifepristone—ABCC1—cortex of kidney—kidney cancer	0.000507	0.0313	CbGeAlD
Mifepristone—ABCC1—cardiac atrium—kidney cancer	0.000483	0.0297	CbGeAlD
Mifepristone—CYP3A5—nephron tubule—kidney cancer	0.000456	0.0281	CbGeAlD
Mifepristone—NR3C1—nephron tubule—kidney cancer	0.000452	0.0279	CbGeAlD
Mifepristone—CYP3A5—renal system—kidney cancer	0.000414	0.0255	CbGeAlD
Mifepristone—NR3C1—renal system—kidney cancer	0.000411	0.0253	CbGeAlD
Mifepristone—CYP3A5—kidney—kidney cancer	0.0004	0.0247	CbGeAlD
Mifepristone—NR3C1—kidney—kidney cancer	0.000397	0.0245	CbGeAlD
Mifepristone—CYP3A5—cortex of kidney—kidney cancer	0.00039	0.024	CbGeAlD
Mifepristone—NR3C1—cortex of kidney—kidney cancer	0.000387	0.0238	CbGeAlD
Mifepristone—NR3C1—gonad—kidney cancer	0.000368	0.0227	CbGeAlD
Mifepristone—NR3C1—cardiac atrium—kidney cancer	0.000368	0.0227	CbGeAlD
Mifepristone—CYP3A4—renal system—kidney cancer	0.000311	0.0191	CbGeAlD
Mifepristone—CYP2D6—renal system—kidney cancer	0.000306	0.0188	CbGeAlD
Mifepristone—CYP3A4—kidney—kidney cancer	0.0003	0.0185	CbGeAlD
Mifepristone—CYP2D6—kidney—kidney cancer	0.000296	0.0182	CbGeAlD
Mifepristone—ABCB1—nephron tubule—kidney cancer	0.000242	0.0149	CbGeAlD
Mifepristone—ABCB1—renal system—kidney cancer	0.00022	0.0136	CbGeAlD
Mifepristone—ABCB1—kidney—kidney cancer	0.000213	0.0131	CbGeAlD
Mifepristone—ABCB1—cortex of kidney—kidney cancer	0.000207	0.0128	CbGeAlD
Mifepristone—ABCB1—gonad—kidney cancer	0.000197	0.0122	CbGeAlD
Mifepristone—Pain—Dactinomycin—kidney cancer	0.000156	0.000994	CcSEcCtD
Mifepristone—Anorexia—Vincristine—kidney cancer	0.000155	0.00099	CcSEcCtD
Mifepristone—Oedema—Gemcitabine—kidney cancer	0.000154	0.000985	CcSEcCtD
Mifepristone—Infection—Gemcitabine—kidney cancer	0.000153	0.000979	CcSEcCtD
Mifepristone—Back pain—Paclitaxel—kidney cancer	0.000153	0.000977	CcSEcCtD
Mifepristone—Dizziness—Vinblastine—kidney cancer	0.000153	0.000976	CcSEcCtD
Mifepristone—Dizziness—Everolimus—kidney cancer	0.000152	0.000972	CcSEcCtD
Mifepristone—Muscle spasms—Paclitaxel—kidney cancer	0.000152	0.000971	CcSEcCtD
Mifepristone—Body temperature increased—Sunitinib—kidney cancer	0.000152	0.00097	CcSEcCtD
Mifepristone—Abdominal pain—Sunitinib—kidney cancer	0.000152	0.00097	CcSEcCtD
Mifepristone—Diarrhoea—Erlotinib—kidney cancer	0.000152	0.00097	CcSEcCtD
Mifepristone—Hypotension—Vincristine—kidney cancer	0.000152	0.00097	CcSEcCtD
Mifepristone—Nervous system disorder—Gemcitabine—kidney cancer	0.000151	0.000966	CcSEcCtD
Mifepristone—Feeling abnormal—Dactinomycin—kidney cancer	0.00015	0.000958	CcSEcCtD
Mifepristone—Haemoglobin—Capecitabine—kidney cancer	0.00015	0.000957	CcSEcCtD
Mifepristone—Skin disorder—Gemcitabine—kidney cancer	0.00015	0.000957	CcSEcCtD
Mifepristone—Haemorrhage—Capecitabine—kidney cancer	0.000149	0.000953	CcSEcCtD
Mifepristone—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000149	0.00095	CcSEcCtD
Mifepristone—Hot flush—Doxorubicin—kidney cancer	0.000148	0.000949	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000148	0.000946	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000147	0.000941	CcSEcCtD
Mifepristone—Menopausal symptoms—Doxorubicin—kidney cancer	0.000147	0.000941	CcSEcCtD
Mifepristone—Hypersensitivity—Sorafenib—kidney cancer	0.000147	0.00094	CcSEcCtD
Mifepristone—Insomnia—Vincristine—kidney cancer	0.000147	0.000939	CcSEcCtD
Mifepristone—Anorexia—Gemcitabine—kidney cancer	0.000147	0.000939	CcSEcCtD
Mifepristone—Oedema peripheral—Capecitabine—kidney cancer	0.000147	0.000938	CcSEcCtD
Mifepristone—Vomiting—Vinblastine—kidney cancer	0.000147	0.000938	CcSEcCtD
Mifepristone—Dizziness—Erlotinib—kidney cancer	0.000147	0.000938	CcSEcCtD
Mifepristone—Ill-defined disorder—Paclitaxel—kidney cancer	0.000147	0.000938	CcSEcCtD
Mifepristone—Connective tissue disorder—Capecitabine—kidney cancer	0.000146	0.000936	CcSEcCtD
Mifepristone—Vomiting—Everolimus—kidney cancer	0.000146	0.000934	CcSEcCtD
Mifepristone—Rash—Everolimus—kidney cancer	0.000145	0.000927	CcSEcCtD
Mifepristone—Dermatitis—Everolimus—kidney cancer	0.000145	0.000926	CcSEcCtD
Mifepristone—Headache—Vinblastine—kidney cancer	0.000145	0.000924	CcSEcCtD
Mifepristone—Angioedema—Paclitaxel—kidney cancer	0.000144	0.000923	CcSEcCtD
Mifepristone—Headache—Everolimus—kidney cancer	0.000144	0.000921	CcSEcCtD
Mifepristone—Hypotension—Gemcitabine—kidney cancer	0.000144	0.00092	CcSEcCtD
Mifepristone—Abdominal pain—Dactinomycin—kidney cancer	0.000144	0.000919	CcSEcCtD
Mifepristone—Body temperature increased—Dactinomycin—kidney cancer	0.000144	0.000919	CcSEcCtD
Mifepristone—Asthenia—Sorafenib—kidney cancer	0.000143	0.000915	CcSEcCtD
Mifepristone—Malaise—Paclitaxel—kidney cancer	0.000143	0.000911	CcSEcCtD
Mifepristone—Hypoglycaemia—Doxorubicin—kidney cancer	0.000142	0.000909	CcSEcCtD
Mifepristone—Hypersensitivity—Sunitinib—kidney cancer	0.000142	0.000904	CcSEcCtD
Mifepristone—Decreased appetite—Vincristine—kidney cancer	0.000141	0.000903	CcSEcCtD
Mifepristone—Pruritus—Sorafenib—kidney cancer	0.000141	0.000903	CcSEcCtD
Mifepristone—Vomiting—Erlotinib—kidney cancer	0.000141	0.000902	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00014	0.000897	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Vincristine—kidney cancer	0.00014	0.000896	CcSEcCtD
Mifepristone—Fatigue—Vincristine—kidney cancer	0.00014	0.000895	CcSEcCtD
Mifepristone—Rash—Erlotinib—kidney cancer	0.00014	0.000894	CcSEcCtD
Mifepristone—Dermatitis—Erlotinib—kidney cancer	0.00014	0.000893	CcSEcCtD
Mifepristone—Insomnia—Gemcitabine—kidney cancer	0.000139	0.000891	CcSEcCtD
Mifepristone—Headache—Erlotinib—kidney cancer	0.000139	0.000888	CcSEcCtD
Mifepristone—Pain—Vincristine—kidney cancer	0.000139	0.000888	CcSEcCtD
Mifepristone—Constipation—Vincristine—kidney cancer	0.000139	0.000888	CcSEcCtD
Mifepristone—Pain in extremity—Doxorubicin—kidney cancer	0.000139	0.000888	CcSEcCtD
Mifepristone—Asthenia—Sunitinib—kidney cancer	0.000138	0.000881	CcSEcCtD
Mifepristone—Dyspnoea—Gemcitabine—kidney cancer	0.000137	0.000878	CcSEcCtD
Mifepristone—Nausea—Vinblastine—kidney cancer	0.000137	0.000876	CcSEcCtD
Mifepristone—Somnolence—Gemcitabine—kidney cancer	0.000137	0.000876	CcSEcCtD
Mifepristone—Nausea—Everolimus—kidney cancer	0.000137	0.000873	CcSEcCtD
Mifepristone—Diarrhoea—Sorafenib—kidney cancer	0.000137	0.000873	CcSEcCtD
Mifepristone—Hypertension—Paclitaxel—kidney cancer	0.000137	0.000872	CcSEcCtD
Mifepristone—Pruritus—Sunitinib—kidney cancer	0.000136	0.000869	CcSEcCtD
Mifepristone—Angiopathy—Capecitabine—kidney cancer	0.000135	0.000864	CcSEcCtD
Mifepristone—Myalgia—Paclitaxel—kidney cancer	0.000135	0.00086	CcSEcCtD
Mifepristone—Arthralgia—Paclitaxel—kidney cancer	0.000135	0.00086	CcSEcCtD
Mifepristone—Mediastinal disorder—Capecitabine—kidney cancer	0.000134	0.000859	CcSEcCtD
Mifepristone—Anxiety—Paclitaxel—kidney cancer	0.000134	0.000857	CcSEcCtD
Mifepristone—Decreased appetite—Gemcitabine—kidney cancer	0.000134	0.000856	CcSEcCtD
Mifepristone—Hypersensitivity—Dactinomycin—kidney cancer	0.000134	0.000856	CcSEcCtD
Mifepristone—Chills—Capecitabine—kidney cancer	0.000134	0.000855	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000134	0.000854	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000133	0.00085	CcSEcCtD
Mifepristone—Discomfort—Paclitaxel—kidney cancer	0.000133	0.00085	CcSEcCtD
Mifepristone—Fatigue—Gemcitabine—kidney cancer	0.000133	0.000849	CcSEcCtD
Mifepristone—Gastrointestinal pain—Vincristine—kidney cancer	0.000133	0.000849	CcSEcCtD
Mifepristone—Dizziness—Sorafenib—kidney cancer	0.000132	0.000844	CcSEcCtD
Mifepristone—Pain—Gemcitabine—kidney cancer	0.000132	0.000842	CcSEcCtD
Mifepristone—Constipation—Gemcitabine—kidney cancer	0.000132	0.000842	CcSEcCtD
Mifepristone—Nausea—Erlotinib—kidney cancer	0.000132	0.000842	CcSEcCtD
Mifepristone—Dry mouth—Paclitaxel—kidney cancer	0.000132	0.000841	CcSEcCtD
Mifepristone—Diarrhoea—Sunitinib—kidney cancer	0.000131	0.00084	CcSEcCtD
Mifepristone—Mental disorder—Capecitabine—kidney cancer	0.000131	0.000835	CcSEcCtD
Mifepristone—Asthenia—Dactinomycin—kidney cancer	0.00013	0.000834	CcSEcCtD
Mifepristone—Malnutrition—Capecitabine—kidney cancer	0.00013	0.000829	CcSEcCtD
Mifepristone—Oedema—Paclitaxel—kidney cancer	0.000129	0.000825	CcSEcCtD
Mifepristone—Abdominal pain—Vincristine—kidney cancer	0.000128	0.000821	CcSEcCtD
Mifepristone—Body temperature increased—Vincristine—kidney cancer	0.000128	0.000821	CcSEcCtD
Mifepristone—Infection—Paclitaxel—kidney cancer	0.000128	0.000819	CcSEcCtD
Mifepristone—Dizziness—Sunitinib—kidney cancer	0.000127	0.000812	CcSEcCtD
Mifepristone—Feeling abnormal—Gemcitabine—kidney cancer	0.000127	0.000812	CcSEcCtD
Mifepristone—Vomiting—Sorafenib—kidney cancer	0.000127	0.000811	CcSEcCtD
Mifepristone—Nervous system disorder—Paclitaxel—kidney cancer	0.000127	0.000809	CcSEcCtD
Mifepristone—Hypokalaemia—Doxorubicin—kidney cancer	0.000126	0.000808	CcSEcCtD
Mifepristone—Rash—Sorafenib—kidney cancer	0.000126	0.000804	CcSEcCtD
Mifepristone—Dermatitis—Sorafenib—kidney cancer	0.000126	0.000804	CcSEcCtD
Mifepristone—Back pain—Capecitabine—kidney cancer	0.000126	0.000802	CcSEcCtD
Mifepristone—Breast disorder—Doxorubicin—kidney cancer	0.000126	0.000802	CcSEcCtD
Mifepristone—Skin disorder—Paclitaxel—kidney cancer	0.000125	0.000801	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000125	0.000799	CcSEcCtD
Mifepristone—Headache—Sorafenib—kidney cancer	0.000125	0.000799	CcSEcCtD
Mifepristone—Muscle spasms—Capecitabine—kidney cancer	0.000125	0.000797	CcSEcCtD
Mifepristone—Diarrhoea—Dactinomycin—kidney cancer	0.000124	0.000795	CcSEcCtD
Mifepristone—Nasopharyngitis—Doxorubicin—kidney cancer	0.000124	0.000794	CcSEcCtD
Mifepristone—Anorexia—Paclitaxel—kidney cancer	0.000123	0.000786	CcSEcCtD
Mifepristone—Muscular weakness—Doxorubicin—kidney cancer	0.000122	0.000783	CcSEcCtD
Mifepristone—Vomiting—Sunitinib—kidney cancer	0.000122	0.000781	CcSEcCtD
Mifepristone—Body temperature increased—Gemcitabine—kidney cancer	0.000122	0.000779	CcSEcCtD
Mifepristone—Rash—Sunitinib—kidney cancer	0.000121	0.000774	CcSEcCtD
Mifepristone—Dermatitis—Sunitinib—kidney cancer	0.000121	0.000773	CcSEcCtD
Mifepristone—Hypotension—Paclitaxel—kidney cancer	0.000121	0.000771	CcSEcCtD
Mifepristone—Ill-defined disorder—Capecitabine—kidney cancer	0.00012	0.000769	CcSEcCtD
Mifepristone—Headache—Sunitinib—kidney cancer	0.00012	0.000769	CcSEcCtD
Mifepristone—Hypersensitivity—Vincristine—kidney cancer	0.00012	0.000765	CcSEcCtD
Mifepristone—Nausea—Sorafenib—kidney cancer	0.000119	0.000758	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000118	0.000751	CcSEcCtD
Mifepristone—Malaise—Capecitabine—kidney cancer	0.000117	0.000748	CcSEcCtD
Mifepristone—Insomnia—Paclitaxel—kidney cancer	0.000117	0.000746	CcSEcCtD
Mifepristone—Asthenia—Vincristine—kidney cancer	0.000117	0.000745	CcSEcCtD
Mifepristone—Vomiting—Dactinomycin—kidney cancer	0.000116	0.000739	CcSEcCtD
Mifepristone—Dyspnoea—Paclitaxel—kidney cancer	0.000115	0.000735	CcSEcCtD
Mifepristone—Somnolence—Paclitaxel—kidney cancer	0.000115	0.000733	CcSEcCtD
Mifepristone—Rash—Dactinomycin—kidney cancer	0.000115	0.000733	CcSEcCtD
Mifepristone—Nausea—Sunitinib—kidney cancer	0.000114	0.000729	CcSEcCtD
Mifepristone—Decreased appetite—Paclitaxel—kidney cancer	0.000112	0.000717	CcSEcCtD
Mifepristone—Hypertension—Capecitabine—kidney cancer	0.000112	0.000716	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000111	0.000712	CcSEcCtD
Mifepristone—Fatigue—Paclitaxel—kidney cancer	0.000111	0.000711	CcSEcCtD
Mifepristone—Diarrhoea—Vincristine—kidney cancer	0.000111	0.00071	CcSEcCtD
Mifepristone—Asthenia—Gemcitabine—kidney cancer	0.000111	0.000707	CcSEcCtD
Mifepristone—Arthralgia—Capecitabine—kidney cancer	0.00011	0.000706	CcSEcCtD
Mifepristone—Myalgia—Capecitabine—kidney cancer	0.00011	0.000706	CcSEcCtD
Mifepristone—Constipation—Paclitaxel—kidney cancer	0.00011	0.000705	CcSEcCtD
Mifepristone—Pain—Paclitaxel—kidney cancer	0.00011	0.000705	CcSEcCtD
Mifepristone—Anxiety—Capecitabine—kidney cancer	0.00011	0.000704	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.00011	0.000701	CcSEcCtD
Mifepristone—Discomfort—Capecitabine—kidney cancer	0.000109	0.000698	CcSEcCtD
Mifepristone—Pruritus—Gemcitabine—kidney cancer	0.000109	0.000697	CcSEcCtD
Mifepristone—Dry mouth—Capecitabine—kidney cancer	0.000108	0.00069	CcSEcCtD
Mifepristone—Nausea—Dactinomycin—kidney cancer	0.000108	0.00069	CcSEcCtD
Mifepristone—Dizziness—Vincristine—kidney cancer	0.000107	0.000687	CcSEcCtD
Mifepristone—Infestation—Doxorubicin—kidney cancer	0.000107	0.000684	CcSEcCtD
Mifepristone—Infestation NOS—Doxorubicin—kidney cancer	0.000107	0.000684	CcSEcCtD
Mifepristone—Feeling abnormal—Paclitaxel—kidney cancer	0.000106	0.00068	CcSEcCtD
Mifepristone—Oedema—Capecitabine—kidney cancer	0.000106	0.000677	CcSEcCtD
Mifepristone—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000106	0.000674	CcSEcCtD
Mifepristone—Diarrhoea—Gemcitabine—kidney cancer	0.000105	0.000674	CcSEcCtD
Mifepristone—Infection—Capecitabine—kidney cancer	0.000105	0.000672	CcSEcCtD
Mifepristone—Nervous system disorder—Capecitabine—kidney cancer	0.000104	0.000664	CcSEcCtD
Mifepristone—Vomiting—Vincristine—kidney cancer	0.000103	0.00066	CcSEcCtD
Mifepristone—Skin disorder—Capecitabine—kidney cancer	0.000103	0.000657	CcSEcCtD
Mifepristone—Urticaria—Paclitaxel—kidney cancer	0.000103	0.000655	CcSEcCtD
Mifepristone—Rash—Vincristine—kidney cancer	0.000102	0.000655	CcSEcCtD
Mifepristone—Dermatitis—Vincristine—kidney cancer	0.000102	0.000654	CcSEcCtD
Mifepristone—Abdominal pain—Paclitaxel—kidney cancer	0.000102	0.000652	CcSEcCtD
Mifepristone—Body temperature increased—Paclitaxel—kidney cancer	0.000102	0.000652	CcSEcCtD
Mifepristone—Headache—Vincristine—kidney cancer	0.000102	0.00065	CcSEcCtD
Mifepristone—Anorexia—Capecitabine—kidney cancer	0.000101	0.000645	CcSEcCtD
Mifepristone—Sinusitis—Doxorubicin—kidney cancer	0.0001	0.000642	CcSEcCtD
Mifepristone—Hypotension—Capecitabine—kidney cancer	9.9e-05	0.000632	CcSEcCtD
Mifepristone—Vomiting—Gemcitabine—kidney cancer	9.8e-05	0.000626	CcSEcCtD
Mifepristone—Rash—Gemcitabine—kidney cancer	9.72e-05	0.000621	CcSEcCtD
Mifepristone—Dermatitis—Gemcitabine—kidney cancer	9.71e-05	0.00062	CcSEcCtD
Mifepristone—Haemoglobin—Doxorubicin—kidney cancer	9.66e-05	0.000617	CcSEcCtD
Mifepristone—Headache—Gemcitabine—kidney cancer	9.66e-05	0.000617	CcSEcCtD
Mifepristone—Nausea—Vincristine—kidney cancer	9.65e-05	0.000617	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Capecitabine—kidney cancer	9.65e-05	0.000617	CcSEcCtD
Mifepristone—Haemorrhage—Doxorubicin—kidney cancer	9.61e-05	0.000614	CcSEcCtD
Mifepristone—Insomnia—Capecitabine—kidney cancer	9.58e-05	0.000612	CcSEcCtD
Mifepristone—Hypersensitivity—Paclitaxel—kidney cancer	9.51e-05	0.000608	CcSEcCtD
Mifepristone—Oedema peripheral—Doxorubicin—kidney cancer	9.47e-05	0.000605	CcSEcCtD
Mifepristone—Connective tissue disorder—Doxorubicin—kidney cancer	9.44e-05	0.000603	CcSEcCtD
Mifepristone—Dyspnoea—Capecitabine—kidney cancer	9.44e-05	0.000603	CcSEcCtD
Mifepristone—Asthenia—Paclitaxel—kidney cancer	9.26e-05	0.000592	CcSEcCtD
Mifepristone—Decreased appetite—Capecitabine—kidney cancer	9.21e-05	0.000588	CcSEcCtD
Mifepristone—Nausea—Gemcitabine—kidney cancer	9.15e-05	0.000585	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Capecitabine—kidney cancer	9.14e-05	0.000584	CcSEcCtD
Mifepristone—Fatigue—Capecitabine—kidney cancer	9.13e-05	0.000583	CcSEcCtD
Mifepristone—Pruritus—Paclitaxel—kidney cancer	9.13e-05	0.000583	CcSEcCtD
Mifepristone—Constipation—Capecitabine—kidney cancer	9.06e-05	0.000579	CcSEcCtD
Mifepristone—Pain—Capecitabine—kidney cancer	9.06e-05	0.000579	CcSEcCtD
Mifepristone—Diarrhoea—Paclitaxel—kidney cancer	8.83e-05	0.000564	CcSEcCtD
Mifepristone—Feeling abnormal—Capecitabine—kidney cancer	8.73e-05	0.000558	CcSEcCtD
Mifepristone—Angiopathy—Doxorubicin—kidney cancer	8.72e-05	0.000557	CcSEcCtD
Mifepristone—Gastrointestinal pain—Capecitabine—kidney cancer	8.66e-05	0.000553	CcSEcCtD
Mifepristone—Mediastinal disorder—Doxorubicin—kidney cancer	8.66e-05	0.000553	CcSEcCtD
Mifepristone—Chills—Doxorubicin—kidney cancer	8.62e-05	0.000551	CcSEcCtD
Mifepristone—Dizziness—Paclitaxel—kidney cancer	8.53e-05	0.000545	CcSEcCtD
Mifepristone—Mental disorder—Doxorubicin—kidney cancer	8.42e-05	0.000538	CcSEcCtD
Mifepristone—Urticaria—Capecitabine—kidney cancer	8.41e-05	0.000538	CcSEcCtD
Mifepristone—Body temperature increased—Capecitabine—kidney cancer	8.37e-05	0.000535	CcSEcCtD
Mifepristone—Abdominal pain—Capecitabine—kidney cancer	8.37e-05	0.000535	CcSEcCtD
Mifepristone—Malnutrition—Doxorubicin—kidney cancer	8.36e-05	0.000535	CcSEcCtD
Mifepristone—Vomiting—Paclitaxel—kidney cancer	8.2e-05	0.000524	CcSEcCtD
Mifepristone—Rash—Paclitaxel—kidney cancer	8.14e-05	0.00052	CcSEcCtD
Mifepristone—Dermatitis—Paclitaxel—kidney cancer	8.13e-05	0.000519	CcSEcCtD
Mifepristone—Back pain—Doxorubicin—kidney cancer	8.09e-05	0.000517	CcSEcCtD
Mifepristone—Headache—Paclitaxel—kidney cancer	8.08e-05	0.000517	CcSEcCtD
Mifepristone—Muscle spasms—Doxorubicin—kidney cancer	8.04e-05	0.000514	CcSEcCtD
Mifepristone—Hypersensitivity—Capecitabine—kidney cancer	7.8e-05	0.000499	CcSEcCtD
Mifepristone—Ill-defined disorder—Doxorubicin—kidney cancer	7.76e-05	0.000496	CcSEcCtD
Mifepristone—Nausea—Paclitaxel—kidney cancer	7.66e-05	0.00049	CcSEcCtD
Mifepristone—Asthenia—Capecitabine—kidney cancer	7.6e-05	0.000486	CcSEcCtD
Mifepristone—Malaise—Doxorubicin—kidney cancer	7.54e-05	0.000482	CcSEcCtD
Mifepristone—Pruritus—Capecitabine—kidney cancer	7.49e-05	0.000479	CcSEcCtD
Mifepristone—Diarrhoea—Capecitabine—kidney cancer	7.25e-05	0.000463	CcSEcCtD
Mifepristone—Hypertension—Doxorubicin—kidney cancer	7.22e-05	0.000461	CcSEcCtD
Mifepristone—Myalgia—Doxorubicin—kidney cancer	7.12e-05	0.000455	CcSEcCtD
Mifepristone—Arthralgia—Doxorubicin—kidney cancer	7.12e-05	0.000455	CcSEcCtD
Mifepristone—Anxiety—Doxorubicin—kidney cancer	7.1e-05	0.000453	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	7.07e-05	0.000452	CcSEcCtD
Mifepristone—Discomfort—Doxorubicin—kidney cancer	7.04e-05	0.00045	CcSEcCtD
Mifepristone—Dizziness—Capecitabine—kidney cancer	7e-05	0.000448	CcSEcCtD
Mifepristone—Dry mouth—Doxorubicin—kidney cancer	6.96e-05	0.000445	CcSEcCtD
Mifepristone—Oedema—Doxorubicin—kidney cancer	6.83e-05	0.000436	CcSEcCtD
Mifepristone—Infection—Doxorubicin—kidney cancer	6.78e-05	0.000433	CcSEcCtD
Mifepristone—Vomiting—Capecitabine—kidney cancer	6.73e-05	0.00043	CcSEcCtD
Mifepristone—Nervous system disorder—Doxorubicin—kidney cancer	6.69e-05	0.000428	CcSEcCtD
Mifepristone—Rash—Capecitabine—kidney cancer	6.68e-05	0.000427	CcSEcCtD
Mifepristone—Dermatitis—Capecitabine—kidney cancer	6.67e-05	0.000426	CcSEcCtD
Mifepristone—Headache—Capecitabine—kidney cancer	6.63e-05	0.000424	CcSEcCtD
Mifepristone—Skin disorder—Doxorubicin—kidney cancer	6.63e-05	0.000424	CcSEcCtD
Mifepristone—Anorexia—Doxorubicin—kidney cancer	6.51e-05	0.000416	CcSEcCtD
Mifepristone—Hypotension—Doxorubicin—kidney cancer	6.38e-05	0.000408	CcSEcCtD
Mifepristone—Nausea—Capecitabine—kidney cancer	6.29e-05	0.000402	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.22e-05	0.000397	CcSEcCtD
Mifepristone—Insomnia—Doxorubicin—kidney cancer	6.17e-05	0.000395	CcSEcCtD
Mifepristone—Dyspnoea—Doxorubicin—kidney cancer	6.09e-05	0.000389	CcSEcCtD
Mifepristone—Somnolence—Doxorubicin—kidney cancer	6.07e-05	0.000388	CcSEcCtD
Mifepristone—Decreased appetite—Doxorubicin—kidney cancer	5.93e-05	0.000379	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.89e-05	0.000377	CcSEcCtD
Mifepristone—Fatigue—Doxorubicin—kidney cancer	5.89e-05	0.000376	CcSEcCtD
Mifepristone—Pain—Doxorubicin—kidney cancer	5.84e-05	0.000373	CcSEcCtD
Mifepristone—Constipation—Doxorubicin—kidney cancer	5.84e-05	0.000373	CcSEcCtD
Mifepristone—Feeling abnormal—Doxorubicin—kidney cancer	5.63e-05	0.000359	CcSEcCtD
Mifepristone—Gastrointestinal pain—Doxorubicin—kidney cancer	5.58e-05	0.000357	CcSEcCtD
Mifepristone—Urticaria—Doxorubicin—kidney cancer	5.42e-05	0.000347	CcSEcCtD
Mifepristone—Body temperature increased—Doxorubicin—kidney cancer	5.4e-05	0.000345	CcSEcCtD
Mifepristone—Abdominal pain—Doxorubicin—kidney cancer	5.4e-05	0.000345	CcSEcCtD
Mifepristone—Hypersensitivity—Doxorubicin—kidney cancer	5.03e-05	0.000321	CcSEcCtD
Mifepristone—Asthenia—Doxorubicin—kidney cancer	4.9e-05	0.000313	CcSEcCtD
Mifepristone—Pruritus—Doxorubicin—kidney cancer	4.83e-05	0.000309	CcSEcCtD
Mifepristone—Diarrhoea—Doxorubicin—kidney cancer	4.67e-05	0.000298	CcSEcCtD
Mifepristone—Dizziness—Doxorubicin—kidney cancer	4.51e-05	0.000288	CcSEcCtD
Mifepristone—Vomiting—Doxorubicin—kidney cancer	4.34e-05	0.000277	CcSEcCtD
Mifepristone—Rash—Doxorubicin—kidney cancer	4.3e-05	0.000275	CcSEcCtD
Mifepristone—Dermatitis—Doxorubicin—kidney cancer	4.3e-05	0.000275	CcSEcCtD
Mifepristone—Headache—Doxorubicin—kidney cancer	4.28e-05	0.000273	CcSEcCtD
Mifepristone—Nausea—Doxorubicin—kidney cancer	4.05e-05	0.000259	CcSEcCtD
Mifepristone—NR3C1—Gene Expression—HSPB1—kidney cancer	1.74e-05	0.000446	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—EIF4EBP1—kidney cancer	1.74e-05	0.000446	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ALAD—kidney cancer	1.74e-05	0.000445	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CCBL1—kidney cancer	1.72e-05	0.000441	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ST3GAL2—kidney cancer	1.69e-05	0.000435	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PSMD7—kidney cancer	1.69e-05	0.000435	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ITPR2—kidney cancer	1.69e-05	0.000434	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.68e-05	0.000432	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.66e-05	0.000426	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ALDH1A1—kidney cancer	1.66e-05	0.000425	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—MYC—kidney cancer	1.64e-05	0.000422	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—JUNB—kidney cancer	1.63e-05	0.000419	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PAK1—kidney cancer	1.63e-05	0.000419	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PSMD7—kidney cancer	1.61e-05	0.000414	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.6e-05	0.00041	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CRABP1—kidney cancer	1.59e-05	0.000407	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—SLC5A3—kidney cancer	1.59e-05	0.000407	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PGK1—kidney cancer	1.59e-05	0.000407	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GLIPR1—kidney cancer	1.58e-05	0.000406	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PPAT—kidney cancer	1.58e-05	0.000406	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.58e-05	0.000404	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.56e-05	0.0004	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—LDHB—kidney cancer	1.56e-05	0.000399	CbGpPWpGaD
Mifepristone—AR—Gene Expression—CDKN2B—kidney cancer	1.56e-05	0.000399	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GSTT1—kidney cancer	1.54e-05	0.000396	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ACHE—kidney cancer	1.54e-05	0.000396	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SLC2A1—kidney cancer	1.53e-05	0.000393	CbGpPWpGaD
Mifepristone—ABCC1—Disease—JUNB—kidney cancer	1.52e-05	0.00039	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PPAT—kidney cancer	1.49e-05	0.000382	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GLIPR1—kidney cancer	1.49e-05	0.000382	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ITPR2—kidney cancer	1.48e-05	0.000379	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—APRT—kidney cancer	1.47e-05	0.000377	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—FH—kidney cancer	1.47e-05	0.000377	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	1.47e-05	0.000376	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—SCARB1—kidney cancer	1.46e-05	0.000375	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—JUNB—kidney cancer	1.45e-05	0.000372	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	1.45e-05	0.000372	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTGS1—kidney cancer	1.45e-05	0.000371	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PSMD7—kidney cancer	1.42e-05	0.000364	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	1.42e-05	0.000364	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ACY1—kidney cancer	1.4e-05	0.000361	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—APRT—kidney cancer	1.38e-05	0.000355	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—FH—kidney cancer	1.38e-05	0.000355	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GPC3—kidney cancer	1.38e-05	0.000355	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CA9—kidney cancer	1.35e-05	0.000346	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.35e-05	0.000346	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ACHE—kidney cancer	1.35e-05	0.000345	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GSTT1—kidney cancer	1.35e-05	0.000345	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—BCHE—kidney cancer	1.34e-05	0.000345	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CA2—kidney cancer	1.34e-05	0.000345	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	1.34e-05	0.000345	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IGF2—kidney cancer	1.33e-05	0.000342	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—SLC5A5—kidney cancer	1.33e-05	0.000341	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN2B—kidney cancer	1.33e-05	0.000341	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ALAD—kidney cancer	1.31e-05	0.000336	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.3e-05	0.000334	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GPC3—kidney cancer	1.3e-05	0.000334	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IGF1R—kidney cancer	1.29e-05	0.000331	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—SLC2A1—kidney cancer	1.28e-05	0.000329	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.28e-05	0.000329	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.28e-05	0.000328	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.28e-05	0.000328	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—SCARB1—kidney cancer	1.27e-05	0.000327	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.27e-05	0.000326	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CA2—kidney cancer	1.27e-05	0.000325	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTGS1—kidney cancer	1.26e-05	0.000324	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—MYC—kidney cancer	1.25e-05	0.000321	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.25e-05	0.000321	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.24e-05	0.000319	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN2B—kidney cancer	1.24e-05	0.000318	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PSMD7—kidney cancer	1.24e-05	0.000317	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.24e-05	0.000317	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ALAD—kidney cancer	1.23e-05	0.000317	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.22e-05	0.000314	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1.2e-05	0.000309	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PGK1—kidney cancer	1.2e-05	0.000307	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SLC5A3—kidney cancer	1.2e-05	0.000307	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PDHB—kidney cancer	1.19e-05	0.000307	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—POMC—kidney cancer	1.19e-05	0.000306	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—CDKN2B—kidney cancer	1.18e-05	0.000303	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.18e-05	0.000302	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—LDHB—kidney cancer	1.17e-05	0.000301	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—BCHE—kidney cancer	1.17e-05	0.000301	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—SLC5A5—kidney cancer	1.16e-05	0.000297	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CRABP1—kidney cancer	1.15e-05	0.000295	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.13e-05	0.00029	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PGK1—kidney cancer	1.13e-05	0.00029	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CCBL1—kidney cancer	1.12e-05	0.000288	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—SLC2A1—kidney cancer	1.12e-05	0.000287	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.12e-05	0.000287	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—LDHB—kidney cancer	1.11e-05	0.000284	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.09e-05	0.000278	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GSTP1—kidney cancer	1.07e-05	0.000275	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ITPR2—kidney cancer	1.07e-05	0.000274	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HIF1A—kidney cancer	1.06e-05	0.000272	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TSC2—kidney cancer	1.06e-05	0.000272	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.06e-05	0.000271	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.03e-05	0.000264	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CA9—kidney cancer	1.02e-05	0.000261	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KDR—kidney cancer	1.01e-05	0.00026	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ABCB1—kidney cancer	1.01e-05	0.00026	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.01e-05	0.000258	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HIF1A—kidney cancer	9.89e-06	0.000254	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TSC2—kidney cancer	9.87e-06	0.000253	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GSTM1—kidney cancer	9.83e-06	0.000252	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GLIPR1—kidney cancer	9.74e-06	0.00025	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PPAT—kidney cancer	9.74e-06	0.00025	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTT1—kidney cancer	9.73e-06	0.00025	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ACHE—kidney cancer	9.73e-06	0.00025	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CA9—kidney cancer	9.6e-06	0.000246	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—MYC—kidney cancer	9.5e-06	0.000244	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	9.49e-06	0.000244	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—APC—kidney cancer	9.35e-06	0.00024	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KIT—kidney cancer	9.35e-06	0.00024	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GSTP1—kidney cancer	9.33e-06	0.000239	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CYP1A1—kidney cancer	9.32e-06	0.000239	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—SCARB1—kidney cancer	9.21e-06	0.000236	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTGS1—kidney cancer	9.12e-06	0.000234	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—FH—kidney cancer	9.05e-06	0.000232	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—APRT—kidney cancer	9.05e-06	0.000232	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PSMD7—kidney cancer	8.94e-06	0.000229	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—POMC—kidney cancer	8.9e-06	0.000228	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ABCB1—kidney cancer	8.83e-06	0.000227	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—BRAF—kidney cancer	8.79e-06	0.000226	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	8.72e-06	0.000224	CbGpPWpGaD
Mifepristone—ABCC1—Disease—APC—kidney cancer	8.71e-06	0.000224	CbGpPWpGaD
Mifepristone—ABCC1—Disease—KIT—kidney cancer	8.71e-06	0.000224	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CRABP1—kidney cancer	8.66e-06	0.000222	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GSTM1—kidney cancer	8.57e-06	0.00022	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GPC3—kidney cancer	8.51e-06	0.000218	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—BCHE—kidney cancer	8.47e-06	0.000218	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	8.44e-06	0.000217	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—SLC5A5—kidney cancer	8.37e-06	0.000215	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CA2—kidney cancer	8.28e-06	0.000212	CbGpPWpGaD
Mifepristone—ABCC1—Disease—BRAF—kidney cancer	8.19e-06	0.00021	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CRABP1—kidney cancer	8.16e-06	0.000209	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MAPK3—kidney cancer	8.14e-06	0.000209	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CYP1A1—kidney cancer	8.13e-06	0.000209	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—SLC2A1—kidney cancer	8.08e-06	0.000208	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ALAD—kidney cancer	8.07e-06	0.000207	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ITPR2—kidney cancer	8.05e-06	0.000207	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MYC—kidney cancer	7.91e-06	0.000203	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ST3GAL2—kidney cancer	7.87e-06	0.000202	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ALDH1A1—kidney cancer	7.7e-06	0.000198	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.65e-06	0.000196	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ITPR2—kidney cancer	7.59e-06	0.000195	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC5A3—kidney cancer	7.38e-06	0.000189	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PGK1—kidney cancer	7.38e-06	0.000189	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ACHE—kidney cancer	7.34e-06	0.000188	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTT1—kidney cancer	7.34e-06	0.000188	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—RAF1—kidney cancer	7.34e-06	0.000188	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—RELA—kidney cancer	7.31e-06	0.000187	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ERBB2—kidney cancer	7.26e-06	0.000186	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—LDHB—kidney cancer	7.24e-06	0.000186	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MTOR—kidney cancer	7.16e-06	0.000184	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SCARB1—kidney cancer	6.95e-06	0.000178	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—POMC—kidney cancer	6.95e-06	0.000178	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ACHE—kidney cancer	6.92e-06	0.000178	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTT1—kidney cancer	6.92e-06	0.000178	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTGS1—kidney cancer	6.88e-06	0.000177	CbGpPWpGaD
Mifepristone—ABCC1—Disease—RAF1—kidney cancer	6.84e-06	0.000176	CbGpPWpGaD
Mifepristone—ABCC1—Disease—ERBB2—kidney cancer	6.77e-06	0.000174	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PSMD7—kidney cancer	6.75e-06	0.000173	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTP1—kidney cancer	6.74e-06	0.000173	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN1B—kidney cancer	6.72e-06	0.000173	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MTOR—kidney cancer	6.68e-06	0.000171	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CD4—kidney cancer	6.67e-06	0.000171	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTGS2—kidney cancer	6.62e-06	0.00017	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL2—kidney cancer	6.58e-06	0.000169	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SCARB1—kidney cancer	6.55e-06	0.000168	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTGS1—kidney cancer	6.48e-06	0.000166	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCND1—kidney cancer	6.41e-06	0.000165	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—JUN—kidney cancer	6.4e-06	0.000164	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—BCHE—kidney cancer	6.4e-06	0.000164	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ABCB1—kidney cancer	6.38e-06	0.000164	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PSMD7—kidney cancer	6.36e-06	0.000163	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CTNNB1—kidney cancer	6.35e-06	0.000163	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SLC5A5—kidney cancer	6.32e-06	0.000162	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CA9—kidney cancer	6.27e-06	0.000161	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN1B—kidney cancer	6.27e-06	0.000161	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MAPK3—kidney cancer	6.2e-06	0.000159	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTM1—kidney cancer	6.2e-06	0.000159	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTEN—kidney cancer	6.19e-06	0.000159	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SLC2A1—kidney cancer	6.1e-06	0.000157	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—POMC—kidney cancer	6.06e-06	0.000156	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MYC—kidney cancer	6.03e-06	0.000155	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—BCHE—kidney cancer	6.03e-06	0.000155	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SLC5A5—kidney cancer	5.95e-06	0.000153	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CTNNB1—kidney cancer	5.92e-06	0.000152	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP1A1—kidney cancer	5.87e-06	0.000151	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	5.82e-06	0.000149	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTEN—kidney cancer	5.77e-06	0.000148	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SLC2A1—kidney cancer	5.75e-06	0.000148	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—VEGFA—kidney cancer	5.59e-06	0.000144	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTGS2—kidney cancer	5.54e-06	0.000142	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CRABP1—kidney cancer	5.33e-06	0.000137	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MAPK3—kidney cancer	5.29e-06	0.000136	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MYC—kidney cancer	5.14e-06	0.000132	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTP1—kidney cancer	5.09e-06	0.000131	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MAPK1—kidney cancer	5.03e-06	0.000129	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ITPR2—kidney cancer	4.96e-06	0.000127	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MAPK3—kidney cancer	4.93e-06	0.000127	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTGS2—kidney cancer	4.83e-06	0.000124	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTEN—kidney cancer	4.83e-06	0.000124	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MYC—kidney cancer	4.8e-06	0.000123	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTP1—kidney cancer	4.79e-06	0.000123	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KRAS—kidney cancer	4.75e-06	0.000122	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MAPK3—kidney cancer	4.7e-06	0.000121	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MAPK1—kidney cancer	4.69e-06	0.00012	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTM1—kidney cancer	4.68e-06	0.00012	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MYC—kidney cancer	4.57e-06	0.000117	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ABCB1—kidney cancer	4.54e-06	0.000116	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTT1—kidney cancer	4.52e-06	0.000116	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ACHE—kidney cancer	4.52e-06	0.000116	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP1A1—kidney cancer	4.43e-06	0.000114	CbGpPWpGaD
Mifepristone—ABCC1—Disease—KRAS—kidney cancer	4.43e-06	0.000114	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTM1—kidney cancer	4.41e-06	0.000113	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—POMC—kidney cancer	4.38e-06	0.000112	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CA—kidney cancer	4.37e-06	0.000112	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SCARB1—kidney cancer	4.28e-06	0.00011	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTGS1—kidney cancer	4.24e-06	0.000109	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TP53—kidney cancer	4.22e-06	0.000108	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTEN—kidney cancer	4.21e-06	0.000108	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP1A1—kidney cancer	4.18e-06	0.000107	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PSMD7—kidney cancer	4.16e-06	0.000107	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CA—kidney cancer	4.07e-06	0.000104	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—BCHE—kidney cancer	3.94e-06	0.000101	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.89e-06	9.99e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.76e-06	9.65e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTGS2—kidney cancer	3.49e-06	8.97e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CA—kidney cancer	3.41e-06	8.75e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—POMC—kidney cancer	3.3e-06	8.48e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTP1—kidney cancer	3.13e-06	8.05e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—POMC—kidney cancer	3.11e-06	7.99e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTEN—kidney cancer	3.05e-06	7.82e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CA—kidney cancer	2.97e-06	7.63e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ABCB1—kidney cancer	2.97e-06	7.62e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTM1—kidney cancer	2.88e-06	7.39e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.73e-06	7.01e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTGS2—kidney cancer	2.64e-06	6.77e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTGS2—kidney cancer	2.48e-06	6.38e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTEN—kidney cancer	2.3e-06	5.9e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTEN—kidney cancer	2.17e-06	5.56e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CA—kidney cancer	2.15e-06	5.52e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—POMC—kidney cancer	2.04e-06	5.23e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTGS2—kidney cancer	1.62e-06	4.17e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CA—kidney cancer	1.62e-06	4.16e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.53e-06	3.92e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTEN—kidney cancer	1.42e-06	3.64e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CA—kidney cancer	9.99e-07	2.56e-05	CbGpPWpGaD
